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Abstract Teledermatology, originating in 1995, has been one
of the first telemedicine services to see the light of day. Two
decades of teledermatology research is summarized in this
review. A literature search was conducted in PubMed.
Search terms included “teledermatology,” “teledermoscopy,”
“tele wound care,” “telederm*,” “(dermatology OR
dermoscopy OR wound care OR skin) AND (telemedicine
OR ehealth or mhealth OR telecare OR teledermatology OR
teledermoscopy).” Inclusion criteria were (i) Dutch or English
written papers and (ii) publication year from 2011 to present
or (iii) (systematic) reviews with publication year before 2011.
One hundred fourteen publications and 14 (systematic) re-
views were included for full text reading. Focus of this review
is on the following outcomes: (i) actors (primary, secondary,
tertiary), (ii) purposes (consultation, triage, follow-up,
education) and subspecialties (tele-wound care, burn care,
teledermoscopy (teledermatoscopy), teledermatopathology,
and mobile teledermatology), (iii) delivery modalities and
technologies (store and forward, real-time interactive, and hy-
brid modalities using web-based systems, email, mobile
phones, tablets, or videoconferencing equipment), (iv) busi-
ness models, (v) integration of teledermatology into national
healthcare systems, (vi) preconditions and requirements for
implementation (security, ethical issues, responsibility,
reimbursement, user satisfaction, technique, and technology
standards), and (vii) added value.
To conclude, teledermatology is an efficient and effective
hea l thcare service compared to in-person care .
Teledermatology reduces patients’ travel time and waiting
time, avoids (unnecessary) dermatologic visits, and improves
access of care to underserved patients.
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Merits
Introduction
Telemedicine, as defined by theWorld Health Organization, is
the use of communication technologies in healthcare for the
exchange ofmedical information for diagnosis, treatment, pre-
vention, research, evaluation, and education over a distance
(1). Teledermatology is a mature and frequently used form of
telemedicine. The first publications about teledermatology
listed in PubMed were published in 1995 (2–5) and the num-
ber has grown exponentially. At the end of the year 2015, the
number of publications in PubMed with search term
“teledermatology” evolved to 477 publications.
The visual character of dermatology makes it well-suited for
telemedicine. Colors of the skin and distribution of skin lesions
provide indications and clues in accurate diagnosing lesions
and rashes (6•). Teledermatology has proven to be comparable
in accuracy rates to in person conventional care concerning
diagnosis, management, and clinical outcomes (7•), clearing
many of the barriers mentioned when teledermatology was first
implemented. However, some barriers in teledermatology re-
main, e.g., security, privacy and legal issues, and the absence of
palpation of the skin (8, 9), but can be solved relatively easy
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through selection of patients by the GP, education, and proper
implementation of the service.
Teledermatology is currently applied throughout all kinds of
medical settings, e.g., in hospital and primary care, nursing
homes, home care settings and is applicable in underserved
and remote areas to deliver care over a distance. Furthermore,
it is applied in countries (e.g., Switzerland, the Netherlands, and
the USA) known for their long patient waiting times and/or
capac i ty l imi t s fo r de rma to log i c consu l t a t ion .
Teledermatology has been used during wars, in military and
maritime settings and reduced the number of medical evacua-
tions (10, 11). Finally, it provides care to patients in developing
countries who have no access to (dermatologic) care (12•).
The aim of this narrative review is to give an overview of
the current status of teledermatology concerning (1) the actors
of teledermatology, (2) the purposes and subspecialties of
teledermatology research, (3) the delivery modalities and tech-
nologies used, (4) business models used, (5) the integration of
teledermatology in national health infrastructures, (6) precon-
di t ions and requirements for implementat ion of
teledermatology, and (7) surplus merits of teledermatology.
Method
A literature search was conducted in PubMed. Search terms
included “teledermatology,” “teledermoscopy,” “tele wound
care,” “telederm*,” “(dermatology OR dermoscopy OR
wound care OR skin) AND (telemedicine OR ehealth or
mhea l t h OR t e l e c a r e OR te l ede rma to l ogy OR
teledermoscopy).” Inclusion criteria were (i) Dutch or
English written papers and (ii) publication year from 2011 to
present or (iii) (systematic) reviews with publication year be-
fore 2011. First, all titles were scanned and all duplicates were
removed. Titles that contained “teledermatology” or had a
relevant focus were included. Secondly, titles and abstracts
were scanned and included if they met the review questions.
All papers without an abstract were scanned quickly and were
included if they focused on teledermatology. Unavailable pub-
l i c a t i on s and pub l i c a t i on s focus i ng so l e ly on
teledermatopathology were excluded. Finally, one reviewer
read all remaining publications and completed a data abstrac-
tion form with publication characteristics and relevance for
every publication. Results discussed in this review were based
on this final selection of the publications and any additional
publications that were cited in one of the publications and met
the inclusion criteria, but were not in the original search result.
Search Results
The literature search, as conducted in November 2015, result-
ed in 787 references and after removal of the duplicates 430
unique publications remained. After title selection, 265 publi-
cations were included for abstract selection and 114 publica-
tions were included for full text reading. Furthermore, 60
(systematic) reviews, published before 2011 were found and
14 of those reviews remained for full reading after title and
abstract selection.
Actors
There are different instances of teledermatology in which actors
are involved. An overview of different actors in
teledermatology is presented in Fig. 1. Primary teledermatology
includes direct communication between the patient and the pri-
mary healthcare provider (i.e., general practitioner (GP), gener-
al nurse) or dermatologists for first diagnosis or referral (6•).
Most common is secondary teledermatology. Patients visit the
GP and the GP communicates or exchanges medical informa-
tion of the patient with the dermatologists. Secondary
teledermatology is used by primary care providers to receive
advice for triage of patient and consults (6•). Other secondary
actors who are not explicitly mentioned in the literature are
health insurance companies and healthcare institutions, e.g.,
burn care centers, nursing homes, and emergency departments.
Tertiary teledermatology concerns the collaboration and com-
munication among dermatologists (13). Finally, patient-assisted
teledermatology is a form of teledermatology in which the pa-
tient interacts directly with a healthcare professional, for exam-
ple in follow-up care in which the patients interacts with a
(public health) nurse or wound-care nurse.
Fig. 1 Actors teledermatology
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Purposes and Subspecialties of Teledermatology
Pak defines the goal of teledermatology as: “to provide the
highest quality of dermatologic care more efficiently by mov-
ing patient information rather than patients” (14).
Teledermatology can be classified by the different purposes
it serves: consultation, triage, follow-up, and education.
Likewise, it is used for screening (of melanoma), wound treat-
ment, (international) knowledge exchange between healthcare
professionals, second opinion, and referrals prevention.
The systematic review of van der Heijden et al. (13) found
different purposes of tertiary teledermatology. Tertiary
teledermatology could be used for receiving an expert opinion
from a more specialized colleague (e.g., academic dermatolo-
gist) or a second opinion. Furthermore, it could be used for
resident training and ongoing medical education (13).
Teledermatopathology, teledermoscopy (teledermatoscopy),
and tele-wound care are subspecialties of teledermatology.
Tele-wound care is a subspecialty used in chronic wound care.
A study of Litzinger et al. found that 83 % of the nurses im-
proved their productivity and efficiency by using video confer-
encing in tele-wound care (15). Tele-wound care reduces (trans-
portation and staff) costs, improves quality of life for chronic
wound patients, and is equally effective to conventional care
(16, 17). Teledermoscopy could be used in the examination of
pigmented skin lesions, for the early detection of skin cancer
and for triage. Coates et al. summarize an accuracy of
teledermoscopic diagnoses, ranging from 75 to 95 % (18). A
new application of teledermoscopy concerns the use of mobile
teledermoscopy.
Burn care telemedicine makes it possible to get expertise
from a healthcare professional of a specialized burn center. It
has been shown to be technically and clinically feasible to
provide burn care telemedicine (19).
Delivery Modalities and Technologies
Teledermatology can be delivered by three different mo-
dalities: store and forward (SAF), real-time (RT) interac-
tive, and hybrid. Choice of a modality depends on the
structure of the local health care system, decisions of stake-
holders, like hospital management and physicians as pro-
spective users of the service, payers such as health insur-
ance companies, and the competences of the referring phy-
sician (12•). Store and forward is the most offered and used
modality in teledermatology (7•, 11, 12•, 20). As described
in the literature, the use of store and forward telehealth is
increasing and real-time use is decreasing (21).
Table 1 summarizes the advantages and disadvantages of
store and forward and real-time interactive technologies. Store
and forward and real - t ime interac t ive modes of
teledermatology have in common that they are independent
of space. These modes are especially beneficial in low-
resource settings and the USA with large distances between
the patient and the dermatologists. By use of these delivery
modalities, dermatologists in other geographic areas could be
reached (7•, 8, 12•, 22).
SAF technology includes the exchange of high-quality digi-
tal images between a general or nurse practitioner and a derma-
tologist or between two dermatologists. Distinctive for a store
and forward mode is that it can be used time independent, mak-
ing it more flexible in practice, fitting in daily workflow, and
applicable for the exchange of information between different
time zones. However, direct interaction between actors is not
possible. Use of SAF technology for delivering teledermatology
services shortens the consultation time compared to real-time
and conventional care, which makes it a lower cost intervention
(9). However, responses are delayed, and patients have to wait
for the advice of the dermatologist (8, 22).
Table 1 Advantages and
disadvantages store and forward
and real-time
Store and forward Real-time interactive
Digital images Videoconferencing
Asynchronous: Synchronous:
Space and time independent, flexible Independent of space, dependent on time, less flexible
No or minimal interaction possible Direct interaction possible sender and recipient
(GP, patient, dermatologist)
Consultation time is short Time consuming
Low costs Expensive and not cost-effective short distance
Medical history and images stored
and transferred, standardized
More clinical (in depth) and complete information
acquired from patient
Response delayed: Immediate response:
Wait between consultation and
advice dermatologist
Advice dermatologist and diagnosis can be obtained
immediately during consultation
High resolution digital images Lower resolution images
Fits better in daily workflow Interferes with daily workflow
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The real-time (RT) interactive modality uses video confer-
encing equipment during a teledermatology consultation. Use
of this modality makes delivery of teledermatology services
location independent but not time independent. RT allows
direct interaction between the general practitioner (GP), pa-
tient, and dermatologists. They should all be available at the
same time, which makes RT consultation scheduling logisti-
cally challenging. Furthermore, RT is time consuming, inter-
rupts the routine workflow, and is more expensive (9, 12•, 14,
22). The duration of the videoconference is mostly as long as
the conventional consultation and is not cost-effective in case
of short travel distances.
Hybrid modalities combine features from SAF and RT.
Direct interaction between healthcare professionals and addi-
tionally viewing high-quality images is possible by use of
hybrid modalities (7•).
Technologies which are used for SAF and RT are web-
based systems or email and videoconferencing equipment.
Furthermore, mobile phones and tablets could be used for
capturing and sending images. Image quality of these devices
has been improved and is no longer a barrier in
teledermatology (9). Mobile teledermatology and mobile
teledermoscopy are specialties that use mobile devices (i.e.,
phones, tablets) while performing teledermatology.
Smartphones and tablets can be used by patients to capture
images and transfer them to their healthcare provider or by
GP’s to send images for advice to a dermatologist.
Business Models
Teledermatology hasmany advantages over current conventional
care modes. However, many teledermatology implementations
fail when the business models behind the service are either not
well understood and subsequently poorly implemented or not
implemented at all. Challenges and issues that should be consid-
ered in business modeling concern, e.g., technology, security and
privacy, legal risks, ethical issues, and reimbursement.
Pak (23) describes five important steps for integrating
teledermatology into a well-defined business process and model:
“(1) understanding how the organization delivers care, (2) ana-
lyzing the alternatives including cost-benefit analysis, (3)
obtaining organizational support, (4) formulating an execution
plan, (5) training staff and monitoring the process.” Defining a
good business and reimbursement model depends on the
teledermatology modality used (SAF, real-time, hybrid), consul-
tation, follow-up, and referral process. If teledermatology is im-
plemented in the appropriate setting, it could increase the access
and quality of care while decreasing costs (23).
A survey (2011) among teledermatology programs in the
USA (20) concluded that 12 of the surveyed programs (33 %)
accepted payments from Medicare, Medicaid, Health
Maintenance Organizations (HMO), private payers, and self-
payers. Furthermore, eight teledermatology programs (22 %)
received federal funding from the Veterans Administration or
US military and two programs (6 %) provided teledermatology
as a voluntary service. Teledermatology programs were reim-
bursed by private payers (N=25, 69 %), by self-payers (N=22,
61 %), Medicaid (N=20, 56 %), Medicare (N=19, 53 %), and
by HMO (N=17, 47 %). Thirty-nine states in the USA receive
some reimbursement for telehealth services provided by
Medicaid (24). Reimbursement of other countries and business
models were not found in our literature search.
In the Netherlands, teledermatology is fully reimbursed and
integrated in the national healthcare system. Teledermatology
was introduced during the first 5 years of this century in small
pilots together with innovating dermatologists and general
practitioners on a regional basis as a part of clinical research,
thus building clinical evidence and broad basic support among
future users. From 2005, health institutions (e.g., KSYOS
TeleMedical Center) that solely focused on providing tele-
medicine and eHealth services, actively implemented
teledermatology in the existing health infrastructure. Pivotal
factors in the successful implementation have been the focus
on change management among and continuous support of
future users in the field. GPs were approached to start with
teledermatology when the local dermatologists were already
on board and could act as local drivers of this new service.
Health workers have been trained and supported during the
process of implementation. The health institutions providing
teledermatology took full responsibility for the entire process
including medical responsibility. They contracted medical
specialists and general practitioners as well as health insurers
and were responsible for quality control. These parties provid-
ed safe and user-friendly transmural electronic health records
that facilitated the process of teledermatology. Finally, from
2005, the health insurers have reimbursed teledermatology,
leading to further increase of its use. This has led to a steady
increase in general practitioners using tele consultation ser-
vices in various fields (e.g., dermatology, ophthalmology, car-
diology, and mental health) from 120 in 2005 to an estimated
5500 in 2015 (60 % of all GP’s in the Netherlands).
Integration in National Healthcare Systems
In 2009, the eHealth survey of the World Health Organization
(WHO) showed that a teledermatology service was
established in only 16 % of the 114 responding countries (25).
Less is published about the integration of teledermatology
in national healthcare systems. In the beginning of 2012, 37
teledermatology programs were active in the USA (20).
Reimbursement is often an obstacle for the implementation
of telemedicine into (national) health care systems (26). The
Veterans Health Administration (VHA) has designed one of
the largest teledermatology programs in the USA (21).
Furthermore, teledermatology has been broadly integrated in
the Dutch Healthcare system since 2006 and is fully
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reimbursed. In 2014, more than 12 % of the GP visits in the
Netherlands was related to dermatological care (27), and in
total 27.2 per 1000 patients in GP practice were referred to a
dermatologist (27). KSYOSTeleMedical Center (28) provides
specialized tele-medical care in the Netherlands. In 2015,
KSYOS Te l eMed i c a l Cen t e r p r ov i d ed 14 , 900
teledermatology (store and forward) consultations in which
3421 GPs and 247 dermatologists were involved. Since the
introduction of teledermatology in 2006, a total of 130,531
teledermatology consultations have been performed by
KSYOS TeleMedical Center in the Netherlands.
Preconditions and Requirements for Implementation
of Teledermatology
Perceived barriers and incentives for implementation of
teledermatology services differ for primary care physicians
and dermatologists and should be taken into account during
the implementation. Equipment costs and management and
staff training are implementation barriers as perceived by pri-
mary care physicians while medical legal liability, diagnostic
reliability, and patient follow-up are barriers for academic der-
matologists (29, 30). Both groups are concerned about the
financial reimbursement of teledermatology (29, 30). In the
Netherlands, lack of reimbursement was not an issue during
the initial introduction among innovators. However, for the
large-scale implementation that has happened in the
Netherlands, reimbursement of dermatologists as well as gen-
eral practitioners has been pivotal.
Various preconditions and requirements should be consid-
ered while implementing a teledermatology program. First of
all, an important precondition for teledermatology is assign-
ment of persons responsible for the service as a whole, by
extension for (in)correct diagnosing and prescribing the asso-
ciated treatment, and reflecting on the legal risks (31, 32).
Secondly, there are some legal and ethical issues. If images
of patients are sent to the dermatologists, instead of the patient
itself, a physical physician-patient relationship does not exist
according to regulations in some countries (32). Each country
has its own laws and regulations that influence implementa-
tion. For example, some states in the USA impose restrictions
in providing teledermatology to other states in which the phy-
sician is not working and licensed, and in the Netherlands
teledermatology between patient and dermatologist is only
allowed when it concerns a follow-up consultation and the
physician-patient relationship has been established in the first
face-to-face consultation. This implied that in order to imple-
ment teledermatology in the Netherlands, both general practi-
tioner and dermatologist had to be contracted by the same
health institution. Doing so, the patient is seen at least once
physically by a health worker, in this case the general practi-
tioner, contracted by the health institution. This is mandatory
in the Netherlands in order to be able to receive reimburse-
ment from the health care insurers.
Thirdly, security is an essential requirement for
teledermatology implementation. Requirements for a secure
teledermatology system described in the literature are privacy,
availability, authentication, authorization, storage and network
security, data encryption, confidentiality, and non-repudiation
(9, 33). Data transmission should be reliable and the system
should be continuously available, easily accessible and there
should be a reliable and secure computer connection.
Furthermore, the technical equipment used for making the
pictures and sending the images should operate properly.
Patients and health care providers should be authorized and
verified by a unique authentication number. Confidential pa-
tient data should be protected, encrypted, and encoded by
transmission. Additionally, the data flow should be logged
and it should be documented which health care provider re-
ceived which information and when. International
Organization for Standardization (ISO) standards, like the
ISO/TS 13131:2014 (34) on Telehealth services or the ISO/
IEC 27001:2013 (35) on information technology security, can
be very useful tools to address these issues.
Fou r t h , a l t hough image s de l i v e r e d th r ough
teledermatology provide a lot of information, additional
(patient) information and medical history is needed for decid-
ing on final diagnoses or treatments. Firstly, data on some
patient demographics (e.g., identification number, name, gen-
der, age etcetera) is required. Furthermore, the patient history
(complaints and symptoms, allergies, medication use etcetera)
and a description of the skin lesion (color, shape, borders, size,
location, surface, number of lesions, distribution, and etcetera)
could provide necessary clues (11, 22). A technological barri-
er concerns the interfacing of the teledermatology application
with the existing electronic medical record (32).
Furthermore, user satisfaction often is a barrier in the accep-
tance of technology and a key factor in the implementation of
teledermatology. Orruño et al. (36) developed the
teledermatology technology acceptance model (based on the
technology acceptance model (TAM) of Davis (37)) and deter-
mined which factors affect the intention of physicians to use
teledermatology. The teledermatology TAM describes the in-
tention of physicians to use teledermatology and the acceptance
of teledermatology in three different contexts: the individual
(compatibility of technology, attitude), the technological (per-
ceived usefulness of technology, perceived ease of use of tech-
nology and habits), and the organizational (facilitators, subjec-
tive norm) factors. Habits, compatibility, facilitators, and sub-
jective norm are additional dimensions to the original TAM.
Habits encompass behavior which is now, with the use of
teledermatology, automatized (36), e.g., do the individuals feel
comfortable with the information and communication technol-
ogy? The developers of the new teledermatology model found
that facilitators (organizational infrastructure, training, and
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support) significantly influence the intention to use
teledermatology (36). Training should include how
teledermatology provides access to timely dermatologic care,
how physicians should take high-quality images and how to
send images securely (38). Especially the organizational con-
text of the teledermatology implementation is very important
(36), do individuals believe that this organizational infrastruc-
ture provides support to use the system? So, implementation
requirements for user acceptance of teledermatology are (1) full
and continuous technical support to users, (2) training of phy-
sicians (3) and an appropriate organizational infrastructure.
The last important factor which should be considered is the
standardization of imaging and equipment of teledermatology
services. There are no universal imaging standards developed
and implemented in teledermatology yet (39). Therefore,
Quigley et al. conducted a systematic review summarizing
technology and technique imaging standards for acquiring
digital dermatologic images (39).
Technology standards include spatial and color resolution,
reproduction ratios, post acquisition image processing, color
calibration, compression, image output, image archiving and
storage, and image security during transmission and storage.
A study (1997) concluded that a resolution of 768×512 pixels
suits teledermatology purposes as well (40). The American
Telemedicine Association’s Practice Guidelines for
teledermatology (2008) advised at least 24 bits of color which
results in 16,777,216 available colors (41). The most recent
American Telemedicine Association guideline (2012) recom-
mended minimal 800×600 pixels and preferred a resolution of
1024×768 pixels for store and forward teledermatology (42).
Technique standards include environmental conditions (i.e.,
lighting, background, camera position), patient pose and standard
view sets, patient consent, privacy, and confidentiality (39).
Environmental conditions affect the quality, appearance, and con-
sistency of images (39). And privacy, security, and confidentiality
standards depend on region specific laws and regulations.
Added Value
One of the benefits of teledermatology is reduction of travel
by patients. A systematic review by Wootton et al. summa-
rized 18–94 % (mean 43 %) of travel was avoided by
teledermatology (43). Another advantage of teledermatology
is the number of dermatologic visits averted and a reduction in
unnecessary in-patient visits. A recent review by Whited (7•)
summarizes that 13–81 % (average 45.5 %) of dermatologic
visits were avoided while using store and forward, and 44.4–
82 % (average 61.5 %) of visits were averted with real-time
interactive teledermatology. As shown by Eminović et al.
(44), teleconsultation reduces the number of unnecessary
physical referrals to the dermatologist leading to lower costs
and higher efficiency. Furthermore, van der Heijden et al. (45)
conclude that teledermatology averts 74 % of physical
referrals and leads to an 18 % cost reduction compared to in-
patient dermatologic care. Teledermatology improves patient
access to dermatologic expertise to patients who were under-
served by dermatology care for geographic reasons (12•). It
further reduces long patient waiting lists, streamlines patient
care, and allows shared decision-making with other physi-
cians. Teledermatology consultation, applied in the right set-
ting, provides care equal to but often more efficient and effec-
tive as physical patient care and at least does not negatively
influence the quality of care delivered to the patient (45, 46).
As described by Landow et al. (47) “teledermatology makes
three promises: better, cheaper and faster dermatologic care.”
Discussion
This narrative literature review of PubMed based on publica-
tions selected by one reviewer focused on the actors, purposes,
subspecialties, delivery modalities and technologies, business
models integration of teledermatology services into national
healthcare systems, preconditions and requirements for imple-
mentation and added value of teledermatology.
Teledermatology is used by healthcare professionals for con-
sultation of other colleagues, triage, and follow-up of patients
and education of more junior healthcare professionals. It en-
ables direct digital communication between the patient and pri-
mary health care provider or dermatologist, between general
practitioners and dermatologists or among dermatologists.
Teledermatology can be delivered by three different modalities:
store and forward, real-time interactive, and hybrid. As pointed
out in the literature, teledermatology has some advantages and
could be beneficial for patient care. Teledermatology reduces
patient travel time, avoids unnecessary referrals, lowers costs,
and improves efficiency of care. More importantly,
teledermatology has proven to be at least equally effective as
physical patient care and does not negatively influence the
quality of care delivered to the patient.
Despite the benefits of teledermatology, experiences of pa-
tients should be taken into account while implementing a
teledermatology program. Because of methodological deficien-
cies in the evidence currently available, satisfactory explanations
of the underlying reasons for patient satisfaction or dissatisfac-
tion with telemedicine are not available (48). Besides, reliable
and validated instruments to measure satisfaction and quality
aspects of teledermatology from a patients’ perspective has not
been developed yet (7•). In the Netherlands, the consumer qual-
ity index (CQ-index) (49), a standardized method for develop-
ing surveys and measuring healthcare quality from the patients’
perspective, was introduced in 2006 in order to promote patient-
centered care. To measure the quality of care delivered through
telemedicine from a patients’ perspective, we are developing a
valid and reliable questionnaire, based on the framework of the
CQ-index. The responses on such a validated CQ-index for
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teleconsultation could be used to enhance the quality of care
delivered by telemedicine, give choice information to healthcare
consumers, advocacy information for patients and patient orga-
nizations to inform their members about the quality of care of
telemedicine services. Additionally, the results could be used by
different stakeholders: by patients to decide about their
healthcare provider; by the public health inspection to measure
the quality of care; by the health insurance companies to decide
about reimbursement; and by the government to monitor quality
of healthcare. Furthermore, as indicated by Whited (50) there is
a “research gap” on the effect of teledermatology on patients’
quality of life. Quality of life is an important outcome measure
for skin diseases and teledermatologymay have a positive effect
on quality of life of patients. Patients do, for example, not have
to visit the dermatologists physically but can visit their GP near-
by. Especially for chronic patients, patient-assisted follow-up
care at home avoids traveling to a physician and long appoint-
ments during work time. Patients can capture images with their
smartphone (when they have time) and send the images to their
healthcare provider.
There are yet some issues that should be considered before
implementing a teledermatology program, e.g., technology,
security and privacy, legal risks, ethical issues, and
reimbursement. Teledermatology has been fully reimbursed and
integrated in the Netherlands and some states in the USA.
Reimbursement has a positive influence on the integration in
national health systems and the number of teleconsultations
conducted in the Netherlands. However, less is published about
the integration of teledermatology in healthcare systems of other
countries. Due to its merits, we yet expect teledermatology
becoming integrated in more healthcare systems in the future.
Nami et al. (51) for example believe that teledermatology will
become more and more integrated in national health services and
clinical practice as smartphones are integrated in our lives. The
number of smartphone users is increasing exponentially and will
enable us to perform teledermatology via mobile applications.
Therefore, we expect that the number of teledermatology services
will increase as well.
There are some shortcomings of this review. First, the
search was conducted in one database only (PubMed) and
no searches were performed in other databases, e.g.,
MEDLINE and EMBASE. Secondly, publications were se-
lected and included by one reviewer, only which could have
resulted in selection bias.
Conclusion
In conclusion, teledermatology provides care, which is of sim-
ilar quality compared to conventional care but often more
efficient and effective. It is a promising technique for geo-
graphically underserved patients and in countries with long
patient wait lists. It reduces costs, wait times, travel time,
and the number of unnecessary referrals. In the future, more
research is needed on the impact of teledermatology on the
quality of life and on validated methods for measuring expe-
riences of patients to ensure that teledermatology services are
viewed as beneficial from the patient perspective.
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